Schlagwort: ‘Procurement’
Deepening the reform of the medical and health care system
On February 25th, the State Council issued the “Opinions on Deepening the Reform of the Medical and Health Care System.” The “Opinion” stipulates that medical institutions should improve the management of drug reimbursement lists, medical service protocols, and medicare settlement or increase the efficiency of medicare payment. Besides, the use of medical insurance funds should be strictly supervised, and insurance fraud will be dealt with according to legislation. In addition, the reform of centralized drug procurement should be deepened, and a pricing system that depends on the market should be established. Moreover, medical institutions should improve their service capacity and standardize new medical services, such as consulting over the internet.
关于深化医疗保障制度改革的意见
来源：医药网 2020.03.06
2月25日，国务院发布《关于深化医疗保障制度改革的意见》。《意见》要求，应完善医保目录、协议、结算管理，提升医保支付效率；完善医保基金监管，依法追究欺诈骗保行为；深化药品集中带量采购制度改革，并建立以市场为主导的药品价格形成机制；增强医疗服务能力，规范“互联网+医疗”等新服务模式发展。
Supervising the drug price and investigating the cost price
On December 6th, the National Medical Insurance Bureau issued the “Opinions on Supervising the Drug Price.” The “Opinion” indicated that a pricing system that depends on the market should be encouraged, and the centralised procurement with defined quantities, of which the drug price depends on the quantities and the bidding process combines with the procurement, should be further implemented. The “Opinion” also stipulated that a pre-warning system of abnormal drug price movements and an investigation system of the cost price of drugs should be established as well.
国家医保局发布文件：监管药品价格 调查成本
来源：医药网 2019.12.09
12月6日，国家医保局发布《关于做好当前药品价格管理工作的意见》（以下简称《意见》）。《意见》指出，坚持市场调节药品价格的总体方向；坚持“带量采购、量价挂钩、招采合一”的方针。《意见》要求，应建立价格供应异常变动监测预警机制，并完善药品价格成本调查工作机制。
Establishing a nationwide unified procurement platform of drugs
On November 29th, the National Health Commission issued the “Notification on Measures of Deepening the Reform of the Medical and Healthcare System depending on the Centralised Procurement and Use of Drugs.” The “Notification” emphasised that a nationwide unified procurement platform based on provincial centralised procurement platforms should be established, in which the drug codes and procurement standards should be unified so that the drug price can be linked together nationwide. In addition, corporate groups, integrated healthcare organisations, private medical institutions, and pharmacies are encouraged to implement centralised procurement to develop a pricing system that depends on the market. The “Notification” also stipulated that the medical insurance administrative agencies instead of hospitals should pay for the drugs to manufacturers and distributors directly.
医药行业变革：建设全国采购平台 全国价格联动
来源：医药网 2019.12.02
11月29日，国家卫健委体制改革司发布《国务院深化医药卫生改革领导小组印发关于以药品集中采购和使用为突破口进一步深化医药卫生体制改革若干政策措施的通知》。《通知》强调，应依托省级集中采购平台构建全国公共采购市场，统一编码、标准和功能规范，推进价格等相关信息互联互通，促进全国价格联动；鼓励探索集团采购、医联体采购等方式形成合理价格，鼓励非公立医疗机构、社会药店等积极参与，共同推动形成以市场为主导的药品价格形成机制；《通知》还要求，应由医保经办机构直接与生产或流通企业结算药品货款。
Standardising DRG (Diagnosis Related Groups) payment
On October 23rd, the National Medical Insurance Bureau issued the “Notification on Technical Specifications and Grouping Plans of Pilot Works of DRG Payment” including the “Technical Specifications of DRG Grouping and Payment” and “Grouping Plans of DRG(CHS-DRG) Payment.” The “Notification” stipulated that because the CHS-DRG covers nearly all treatments of diseases, it will become the only standard for DRG payment implemented by the National Medical Insurance. In addition, pilot cities of DRG payment should execute the “Grouping Plan” and formulate local subdivided DRGs according to the unified guidelines of grouping and the actual situation of each city.
国家医保局发文 DRG付费标准正式走向统一
来源： 医药网 2019.10.25
10月23日，国家医保局正式公布《关于疾病诊断相关分组（DRG）付费国家试点技术规范和分组方案的通知》，包含《国家医疗保障DRG分组与付费技术规范》和《国家医疗保障DRG（CHS-DRG）分组方案》。《通知》指出，CHS-DRG可基本实现疾病治疗全覆盖，将成为全国医保部门实行DRG付费的唯一标准；各试点城市应严格执行《分组方案》，按照统一的分组操作指南，并结合各地实际情况制定本地的细分DRG分组。
Improving the supply system of shortage medicines
Recently, the General Office of the State Council issued the “Guiding Opinions on Maintaining the Price and Supply of Shortage Medicines.” The “Guiding Opinion” stipulated that a national multi-source information collection platform for shortage medicines and a monitoring system for this platform should be established to realise information sharing of APIs (Active Pharmaceutical Ingredient) and pharmaceutical preparations in terms of their registration, production, procurement, and price. As for the drugs in the shortages list, pharmaceutical enterprises are allowed to quote their price on the provincial-level centralised drug procurement platform or on the internet so that medical institutions can purchase them on demand.
国办：强化药品价格常态化监管 完善短缺药品供应体系
来源：医药网 2019.10.14
近日，国务院办公厅印发《关于进一步做好短缺药品保供稳价工作的意见》（以下简称《意见》）。《意见》指出，应建立国家短缺药品多源信息采集平台和协同监测机制，实现原料药和制剂在注册、生产、采购、价格等方面的信息联通共享；对于短缺药品清单中的品种，允许企业在省级药品集中采购平台上自主报价、直接挂网，医疗机构自主采购。
Nationwide implementation of National Organised Centralised Procurement and Use of Drugs
On September 24th, 2019, more than 20 provinces and districts all over the country have launched a joint procurement of drugs. Thereby the pilot work on National Organised Centralised Procurement and Use of Drugs is extended from 11 big cities to nationwide. The price of all medicines was lower than the price of selected drugs in “4+7.”
医保局：国家组织药品集中采购和使用试点扩至全国
来源：医药网 2019.09.25
9月24日，全国二十多个省、区启动药品联合招标采购，国家组织药品集中采购和使用试点由11个城市扩大至全国。在此次扩围采购中，药品价格都降低到不高于此前11个试点城市中选价格的水平。
Catalog of medical insurance (2019 Version) is released
On August 21st, the State Council issued the “National Medicine Catalogue of Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance (2019 version),” which will be implemented from January 1st, 2020. The “Medicine Catalogue” Indicates that each provincial Medical Insurance Bureau should bring all the drugs of the “Medicine Catalogue” into the “Centralised Procurement” and update the drug database according to the use of drugs in local medical institutions and retail pharmacies. Meanwhile, a national unified drug database should be established to realise the unified management of codes of western medicine, Chinese traditional medicine, and hospital-made medicines.
2019版国家医保目录正式发布
来源：医药网 2019.08.21
8月21日，国务院发布《国家基本医疗保险、工伤保险和生育保险药品目录》（以下简称《目录》），并自2020年1月1日起开始实施。《目录》要求，各省级医疗保障部门应及时将《目录》内药品纳入当地药品集中采购范围，并根据辖区内医疗机构和零售药店药品使用情况，及时更新完善药品数据库。同时，应建立完善全国统一的药品数据库，实现西药、中成药、中药饮片、医院制剂的编码统一管理。
Heilongjiang: The detailed rules of drug price supervision is going to be implemented
On August 9th, the Medical Insurance Bureau of the Heilongjiang province issued the “Notification of Supervising Drug Price and Distribution Information.” The “Notification” stipulates that the supervision of drug price and distribution information should be carried from drug manufacturers, distribution enterprises, medical institutions, retail pharmacies, and public sentiment. The mechanisms for information collection, reporting, analysis, investigation, and processing should be improved at the provincial, city, and county levels.
药品价格监测地方细则来了！月月报送、五方联动……
来源：医药网 2019.08.12
8月9日，黑龙江省医保局发布了《关于做好药品价格和配送信息检测工作的通知》（以下简称《通知》）。《通知》指出，应从药品生产企业、配送企业、医疗机构、定点零售药店和社会舆情五个方面开展药品价格和配送信息检测；健全并完善省、市、县三级联动的信息采集、报送、分析、调查、处理机制。
The Xi’an Municipal Government launches the submission of increased purchase of selected drugs(“4+7”)
On August 6th, the Xi’an Municipal Government issued the “Notification on Launching the Submission of Increased Purchase of Selected Drugs in Xi’an from the ‘Office of the Leading Group for the Implementation of Centralized Drug Procurement and Pilot Work’”. It is decided to increase the purchase of selected drugs in Xi’an because its procurement exceeds expectations. Besides, the deferred payment of the increased procurement should be paid in time.
“4+7″采购量完成超预期，启动中选药品增加采购量报送
来源：医药网 2019.08.07
8月6日，西安市发布《落实国家组织药品集中采购和试点工作领导小组办公室关于启动西安地区中选药品增加采购量报送工作的通知》。因西安地区”4+7″准备采购量完成情况已经超过预期，经研究，决定启动西安地区中选药品增加采购量报送工作。同时，对于增加的采购量，应确保及时回款。
Major Tasks of Medical Reform in 2019
On June 4th, the General Office of the States Council officially issued the “Notification of Major Tasks of deepening the reform of the medical and health system in 2019.” The “Notification” clarifies that the National Health Commission should issue a list of drugs that are suggested to be imitated. The State Medical Insurance Bureau and other departments should promote the national organized centralized procurement and use of drugs, and strengthen the supervision of the quality of selected drugs, the priority use of selected drugs in public medical institutions of pilot areas, the payment settlement, and the production of both selected drugs and raw materials. Besides, these departments should also accelerate the reform of medical insurance payment methods and carry out the pilot program of DRGS payment.
2019医改重点任务：推进药品集中采购试点
来源：医药网 2019.06.05
核心提示：6月4日，国务院办公厅正式发布《深化医药卫生体制改革2019年重点工作任务的通知》。《通知》明确，国家卫生健康委应发布鼓励仿治药品目录; 国家医保局等部门推进国家组织药品集中采购和使用试点，加强对中标药品质量、试点地区公立医疗机构优先使用和药款结算、中标药品及原料药生产的检测等工作。另外，应加快推进医保支付方式改革，开展按疾病诊断相关分组付费试点。